LifeStance Health Group (LFST) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
LifeStance Health Group (LFST) reported a Q3 loss of $0.02 per share, which was better than the Zacks Consensus Estimate of a $0.07 loss. This is an improvement from the $0.17 loss per share reported a year ago.
November 07, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeStance Health Group reported a smaller-than-expected Q3 loss of $0.02 per share, beating the Zacks Consensus Estimate of a $0.07 loss. This marks an improvement from the previous year's $0.17 loss per share.
The better-than-expected earnings report is likely to have a positive impact on LFST's stock price in the short term. The improvement from the previous year's loss also suggests positive momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100